Neathera Inc. is a clinical-stage biotechnology company designing and accelerating the development of next-generation antibody therapies. We are singularly focused on establishing a highly efficient platform that bridges novel drug discovery and industrial-scale manufacturing, ultimately delivering targeted therapies for autoimmune and inflammatory diseases.